Trevi Therapeutics (NASDAQ:TRVI) Earns Outperform Rating from Analysts at Leerink Partners
Leerink Partners began coverage on shares of Trevi Therapeutics (NASDAQ:TRVI – Free Report) in a research report released on Monday morning, Marketbeat.com reports. The brokerage issued an outperform rating and a $7.00 price objective on the stock. Other research analysts also recently issued research reports about the company. Rodman & Renshaw began coverage on Trevi […]
More Stories
What is Snapchat Planet Order? Meaning, Origin, and More Details
Snapchat is one of the most widely used social media platforms. It stands neck to neck with other popular social...
Is The Amazing Digital Circus Renewed? Know about its Release Date
Are you also a fan of adult anime shows? Good news, everyone’s favourite fantasy drama, The Amazing Digital Circus, aka...
Tex Mex Motors Season 3 Updates and Renewal Details
The 2023 premiere series, Tex Mex Motors, is a reality TV show. The series has 2 seasons with episodes showing...
Grown Ups 3: Release Date, Cast Members, and Trailer Updates
About 16 years after its release, the comedy film Grown Ups is finally getting a sequel. The famous group of...
Ripe for the Picking Season 2: Release Date, Cast, and More
Ripe for the Picking is a Japanese manga series. It was first released as a magazine before becoming a web...
Lupin Part 4: Release Date, Cast Members, and Trailer
One of the most popular and engaging mystery thriller series, Lupin, is returning for its fourth part. The series was...